COIL — Coiled Therapeutics Share News
0.000.00%
Brief: Roquefort Therapeutics Says Deadline For Lyramid Sale Extended To 31 August 2025
Roquefort Theraptcs. - Issue of Equity
Roquefort Theraptcs. - Notice of Annual General Meeting
Roquefort Theraptcs. - Corporate Update
Roquefort Theraptcs. - Annual Report & Financial Statements - 31 Dec 2024
Roquefort Theraptcs. - Private Placing and Conversion of CLNs
Brief: Roquefort Therapeutics Says Ajan Reginald To Resign as CEO
Roquefort Theraptcs. - Board Changes
Brief: Roquefort Therapeutics To Sell Oncogeni Unit To Nations Trust Holding For $12 Million
Roquefort Theraptcs. - Proposed Sale of Oncogeni Ltd
Roquefort Theraptcs. - Update on Sale of Lyramid
Roquefort Theraptcs. - Director/PDMR Shareholding
Brief: Roquefort Therapeutics Signs Agreement To Sell Lyramid For $10.8 Mln
Roquefort Theraptcs. - Share Purchase Agreement Signed - Sale of Lyramid
UK's Roquefort Therapeutics surges on proposed sale of unit Lyramid
Brief: Roquefort Therapeutics To Sell Lyramid For Minimum $10 Mln
Roquefort Theraptcs. - Proposed Sale of Midkine Portfolio
Roquefort Theraptcs. - Director Share Distribution
Roquefort Theraptcs. - Conversion of Convertible Loan Notes